Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 8:43 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 49–72 of 9,538 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: HEARTS Clear all

Conditions: Congestive Heart Failure, Emotions, Patient Compliance
Interventions: PP-based health behavior intervention; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Congestive Heart Failure
Interventions: Oral R,R'-Fenoterol, Oral Racemic Fenoterol; Drug
Lead sponsor: National Institute on Aging (NIA); NIH
Eligibility: 21 Years to 60 Years
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Heart Failure NYHA Class III, Heart Failure
Interventions: Cordella PA Sensor System, Standard of Care Pharmacologic Therapy; Device · Drug
Lead sponsor: Endotronix, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 2,150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Naperville, Illinois

Conditions: Stress, Blood Pressure
Interventions: Paint Night; Behavioral
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Obesity, Body Composition, Blood Pressure, Cardiovascular Diseases
Interventions: low carbohydrate diet, low fat diet; Behavioral
Lead sponsor: Tulane University Health Sciences Center; Other
Eligibility: 22 Years to 75 Years
Enrollment: 148 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: New Orleans, Louisiana

Conditions: Chronic Total Occlusion, Occlusion
Interventions: Chronic total occlusion percutaneous coronary intervention; Procedure
Lead sponsor: Minneapolis Heart Institute Foundation; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Cardiac Sarcoidosis
Interventions: hybrid PET/MRI; Diagnostic Test
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Blood Pressure
Interventions: L-tyrosine, Sugar Pill; Dietary Supplement
Lead sponsor: New York Institute of Technology; Other
Eligibility: 40 Years to 84 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Old Westbury, New York

Conditions: Percutaneous Coronary Intervention
Interventions: PEP; Drug
Lead sponsor: Christopher J. McLeod; Other
Eligibility: 21 Years to 85 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Acute Coronary Syndrome
Interventions: Triage CardioProfilER (Troponin I, Myoglobin, CK-MB, BNP); Device
Lead sponsor: Abbott RDx Cardiometabolic; Other
Eligibility: 21 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2003
U.S. locations: 6
States / cities: Sacramento, California • Detroit, Michigan • Charlotte, North Carolina + 3 more

Conditions: Heart Failure
Interventions: Epclusa; Drug
Lead sponsor: Baylor Research Institute; Other
Eligibility: 18 Years to 90 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2026
U.S. locations: 3
States / cities: Los Angeles, California • Durham, North Carolina • Dallas, Texas

Conditions: Coronary Artery Disease (CAD)
Interventions: M118, Unfractionated Heparin; Drug
Lead sponsor: Momenta Pharmaceuticals, Inc.; Industry
Eligibility: 19 Years and older
Enrollment: 503 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 37
States / cities: Little Rock, Arkansas • Washington D.C., District of Columbia • Fort Lauderdale, Florida + 33 more

Conditions: Respiratory Distress Syndrome
Interventions: Transcutaneous Biopac Electrical Stimulator; Device
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Heterozygous Familial Hypercholesterolemia, Coronary Artery Disease
Interventions: mipomersen sodium, placebo; Drug
Lead sponsor: Kastle Therapeutics, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 124 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 37
States / cities: La Jolla, California • Los Angeles, California • Mission Viejo, California + 31 more

Conditions: Obesity, Heart Failure With Normal Ejection Fraction
Interventions: UFA dietary recommendations; Behavioral
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Breast Cancer, Breast Neoplasm Female
Interventions: Walking; Behavioral
Lead sponsor: University of Nebraska; Other
Eligibility: Female only
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Head and Neck Carcinoma
Interventions: Interview, Medical Device Usage and Evaluation, Questionnaire Administration, Virtual Technology Intervention; Other
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Duarte, California

Conditions: Pregnancy, Labor Pain
Interventions: Routine oxytocin, Half-dose oxytocin; Drug
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 172 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2021
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Heart Failure
Interventions: The Wise System; Device
Lead sponsor: EBR Systems, Inc.; Industry
Eligibility: 22 Years and older
Enrollment: 320 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2032
U.S. locations: 12
States / cities: Mesa, Arizona • Scottsdale, Arizona • Jonesboro, Arkansas + 9 more

Conditions: Radial Artery Spasm, Angina, Coronary Artery Disease
Interventions: Topical Nitroglycerine, Topical Lidocaine; Drug
Lead sponsor: Aultman Health Foundation; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Canton, Ohio

Conditions: Obesity, Physical Activity, Exercise
Interventions: Exercise instruction with motivational interview, Self-monitoring; Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 59 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Scottsdale, Arizona

Conditions: Cardiovascular-kidney-metabolic Syndrome, Cardiovascular Diseases, Hypertension, Diabetes, Hyperlipidemia, Kidney Disease, Obesity, Smoking
Interventions: Inspire HER Intervention; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 30 Years to 79 Years · Female only
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Heart Failure, Acute Decompensated Heart Failure
Interventions: Impella BTR; Device
Lead sponsor: Abiomed Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 6
States / cities: Atlanta, Georgia • Evanston, Illinois • Boston, Massachusetts + 2 more

Conditions: Heart Failure, Systolic
Interventions: Autologous cell therapy, Sham; Biological · Other
Lead sponsor: BioCardia, Inc.; Industry
Eligibility: 21 Years to 90 Years
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2025
U.S. locations: 20
States / cities: Phoenix, Arizona • Los Angeles, California • Palo Alto, California + 17 more

Search by objective public record fields.

Researching Emotions And Cardiac Health (REACH): Phase II

Initial Study of Fenoterol as a Treatment for Heart Failure

Real World Effectiveness of the Cordella Pulmonary Artery Sensor System in Patients With Chronic Heart Heart Failure

Art for Hearts/Black Women's Hearts Paint Night

Study of Macronutrients and Heart Disease Risk

Impact of CTO PCI (Chronic Total Occlusion Percutaneous Intervention) on Regular Physical Activity

Feasibility and Accuracy of Hybrid Magnetic Resonance and Positron Emission Tomography With 18F-Fluorodeoxyglucose in Diagnosing Cardiac Sarcoidosis

The Effects of L-Tyrosine on 24 Hour Blood Pressure and Heart Rate in Parkinson's Disease

Safety Evaluation of Intracoronary Infusion of Extracellular Vesicles in Patients Following Coronary Stent Implantation

Rapid Assessment of Cardiac Markers for the Evaluation of Acute Coronary Syndrome (RACE-ACS)

Transplant of Redeemed Organs by Judicious Administration of New Direct-Acting Antivirals for Hepatitis-C Heart Recipients

Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)

Spinal Cord Stimulation to Shorten Ventilator Dependence in ARDS Patients

Efficacy and Safety Study of ISIS 301012 (Mipomersen) as Add-on in Familial Hypercholesterolemic Patients With Coronary Artery Disease

Unsaturated Fatty Acids to Improve Cardiorespiratory Fitness in Obesity and HFpEF

Study on Physical Activity's Relationship With Cancer and Cognition

Virtual Reality Interventions for the Improvement of Depression, Anxiety and Pain in Patients With Head and Neck Cancer and Caregivers

Association Between Fluid Administration, Oxytocin Administration, and Fetal Heart Rate Changes

The WiSE®-UP Study (The WiSE System Utilization & Performance Study)

Topical Nitroglycerine Treatment for Radial Artery Spasm Prevention

Connected Health Care in Exercise Program for Obesity

Inspire HER: Inspiring the Heart and Emotions for Radical Health

Use of the Impella BTR™ in Patients With Heart Failure: An Early Feasibility Study

CardiAMP™ Cell Therapy for Heart Failure Trial